Taken together, these results suggest PBRM1 depleted ccRCC cells exist in a pro-apoptotic, “primed” state, increasing their susceptibility to cell-death-targeted agents like MCL1 inhibitors. The gene discussed is MCL1; the disease is nonpapillary renal cell carcinoma.